Andrew Turitz - Mar 1, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
EVP, CORPORATE DEVELOPMENT
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Mar 1, 2024
Transactions value $
-$97,008
Form type
4
Date filed
3/5/2024, 04:08 PM
Previous filing
Dec 5, 2023
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Sale -$7.15K -475 -1.85% $15.06 25.2K Mar 1, 2024 Direct F1
transaction TDOC Common Stock Options Exercise +4.23K +16.77% 29.4K Mar 1, 2024 Direct F2
transaction TDOC Common Stock Options Exercise +437 +1.49% 29.9K Mar 1, 2024 Direct F2
transaction TDOC Common Stock Options Exercise +867 +2.9% 30.7K Mar 1, 2024 Direct F2
transaction TDOC Common Stock Options Exercise +1.35K +4.39% 32.1K Mar 1, 2024 Direct F3
transaction TDOC Common Stock Options Exercise +12.4K +38.66% 44.5K Mar 1, 2024 Direct F3
transaction TDOC Common Stock Options Exercise +1.15K +2.58% 45.6K Mar 1, 2024 Direct F3
transaction TDOC Common Stock Sale -$89.9K -6.19K -13.57% $14.52 39.4K Mar 4, 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Award $0 +12.7K $0.00 12.7K Mar 1, 2024 Common Stock 12.7K Direct F5, F6, F7
transaction TDOC Performance Stock Units Options Exercise $0 -4.23K -33.33% $0.00 8.45K Mar 1, 2024 Common Stock 4.23K Direct F2, F8
transaction TDOC Performance Stock Units Options Exercise $0 -437 -100% $0.00* 0 Mar 1, 2024 Common Stock 437 Direct F2, F9
transaction TDOC Performance Stock Units Options Exercise $0 -867 -100% $0.00* 0 Mar 1, 2024 Common Stock 867 Direct F2, F10
transaction TDOC Restricted Stock Units Options Exercise $0 -1.35K -20% $0.00 5.39K Mar 1, 2024 Common Stock 1.35K Direct F3, F11
transaction TDOC Restricted Stock Units Options Exercise $0 -12.4K -33.33% $0.00 24.8K Mar 1, 2024 Common Stock 12.4K Direct F3, F12
transaction TDOC Restricted Stock Units Options Exercise $0 -1.15K -100% $0.00* 0 Mar 1, 2024 Common Stock 1.15K Direct F3, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 27, 2023.
F2 Performance stock units convert to shares of TDOC common stock on a one-for-one basis
F3 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F4 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F5 Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
F6 Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
F7 The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8 On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F9 On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
F10 On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
F11 On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F12 On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F13 On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.